Genmab A/S
Close on Nov 19, 2026
Genmab A/S SG&A & Commercial Employees at Period-End (FTEs): 1,163 in Q3 2026, up 38.5% from a year earlier. That is the highest of the 30 quarters on record here.
Where the Q3 2026 figure comes from
“|| Selling, general and administrative employees | 1,163 | 840”
Source: Genmab Form 6-K — Q3 2026 Interim Report (Nine Months Ended Sep 30, 2026) ↗
Consolidated commercialization, medical affairs, field sales, and corporate administrative FTEs (35.9% of total workforce as of Q3 2026).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Genmab A/S SG&A & Commercial Employees at Period-End (FTEs), quarterly Q1 2019–Q3 2026 [Data set]. Compiled from Genmab A/S SEC filings and investor materials. https://stockdatahq.com/stocks/gmab/kpis/fte-sga
See every metric in the Genmab A/S KPI table. Data updated Nov 11, 2026.
See a number that looks wrong?